Larvol Delta - Successful-and-RiskMinimizing-Treatment-of-Ulcerative-Colitis-by-Positive-Switch-from-JAK-Inhibitors-to-Ustekinumab

Stelara (ustekinumab) - J&J

Jyseleca (filgotinib) - Gilead

Rinvoq (upadacitinib) - AbbVie

Entyvio (vedolizumab) - Takeda

http://www.ncbi.nlm.nih.gov/pubmed/41867665

Haruka Otake; Hirosato Mashima; Satohiro Matsumoto

Mar 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next